IBN Coverage Clene Paves Cash Runway to Advance CNM-Au8 for ALS
| CLNN Stock | USD 4.49 0.26 5.47% |
About 69% of Clene's investor base is looking to short. The analysis of the overall investor sentiment regarding Clene Inc suggests that many traders are alarmed. Clene's investing sentiment overview a quick insight into current market opportunities from investing in Clene Inc. Many technical investors use Clene Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Clene |
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community. LOS ANGELES - January 13, 2025 - Clene and its wholly owned subsidiary, Cl...
Read at finance.yahoo.com
 |
Clene Fundamental Analysis
We analyze Clene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Clene is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Clene Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Clene stock to make a market-neutral strategy. Peer analysis of Clene could also be used in its relative valuation, which is a method of valuing Clene by comparing valuation metrics with similar companies.
Peers
Clene Related Equities
| IMNM | Immunome | 4.95 | ||||
| CSBR | Champions Oncology | 2.71 | ||||
| KZR | Kezar Life | 0.78 | ||||
| NXTC | NextCure | 0.63 | ||||
| MLYS | Mineralys Therapeutics, | 0.29 | ||||
| IPSC | Century Therapeutics | 0.12 | ||||
| IKNA | Ikena Oncology | 0.67 | ||||
| HOWL | Werewolf Therapeutics | 0.74 | ||||
| NKTX | Nkarta | 0.85 | ||||
| MOLN | Molecular Partners | 1.34 | ||||
| SNSE | Sensei Biotherapeutics | 2.08 | ||||
| MNOV | MediciNova | 3.41 | ||||
| FHTX | Foghorn Therapeutics | 3.46 | ||||
| NUVB | Nuvation Bio | 3.75 |
Check out Clene Hype Analysis, Clene Correlation and Clene Performance. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clene. If investors know Clene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.614 | Earnings Share (5.29) | Revenue Per Share | Quarterly Revenue Growth (0.66) | Return On Assets |
The market value of Clene Inc is measured differently than its book value, which is the value of Clene that is recorded on the company's balance sheet. Investors also form their own opinion of Clene's value that differs from its market value or its book value, called intrinsic value, which is Clene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clene's market value can be influenced by many factors that don't directly affect Clene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.